FAP and liver cancer: Because human hepatic cancer cells lack the expression of FAP (Figure 2A), combining with the cytolytic potential of hFAP-CAR T cells to primary CAFs from several tumor types (Figure 3), above data could suggest that it was through eliminating microenvironmental CAFs that FAP-CAR T cells slowed tumor growth in the PDX model.